189 related articles for article (PubMed ID: 7798789)
41. A role for phospholipid-derived inflammatory mediators in intestinal anaphylaxis in the rat.
MacNaughton WK; Catto-Smith AG; Gall DG
J Pharmacol Exp Ther; 1992 Feb; 260(2):773-9. PubMed ID: 1738123
[TBL] [Abstract][Full Text] [Related]
42. Presence of immunoreactive platelet-activating factor in peritoneal exudate induced by zymosan in rats.
Damas J; Prunescu P
Arch Int Pharmacodyn Ther; 1993; 322():115-23. PubMed ID: 8215712
[TBL] [Abstract][Full Text] [Related]
43. Three-quarters nephrectomy in rats as a model of early renal failure.
Takahashi S; Okada K; Nagura Y; Hatano M; Ise M; Hayashi H; Uehara Y
Nihon Jinzo Gakkai Shi; 1991 Jan; 33(1):27-31. PubMed ID: 2038129
[TBL] [Abstract][Full Text] [Related]
44. The role of angiotensin-II in progressive diabetic glomerulopathy in the rat.
Whiteside CI; Thompson J
Endocrinology; 1989 Oct; 125(4):1932-40. PubMed ID: 2551633
[TBL] [Abstract][Full Text] [Related]
45. Preventive effect of platelet-activating factor antagonist, Y-24180, against cyclosporine-induced acute nephrotoxicity.
Kawaguchi A; Sugimoto K; Fujimura A
Life Sci; 2001 Jan; 68(10):1181-90. PubMed ID: 11228102
[TBL] [Abstract][Full Text] [Related]
46. Beneficial effect of the platelet-activating factor antagonist WEB 2170 on reperfusion injury after orthotopic liver transplantation.
Spiegel HU; Oldhafer KJ; Lang H; Schüttler W; Bremer C; Pichlmayr R
Transplant Proc; 1995 Oct; 27(5):2884-5. PubMed ID: 7482955
[No Abstract] [Full Text] [Related]
47. Thromboxane mediates the renal hemodynamic effects of platelet activating factor.
Yoo J; Schlondorff D; Neugarten J
J Pharmacol Exp Ther; 1990 May; 253(2):743-8. PubMed ID: 2140130
[TBL] [Abstract][Full Text] [Related]
48. [Effects of onpi-to (TJ-8117) and (-)epicatechin-3-O-gallate on the proliferating changes in glomeruli of 5/6 nephrectomized rats].
Fujitsuka N; Kurogi A; Hattori T; Shindo S
Nihon Jinzo Gakkai Shi; 1997 Oct; 39(7):693-700. PubMed ID: 9396236
[TBL] [Abstract][Full Text] [Related]
49. Kidney function in rats after 5/6 nephrectomy (5/6 NX); effort of treatment with vitamin E.
Bräunlich H; Marx F; Fleck C; Stein G
Exp Toxicol Pathol; 1997 Feb; 49(1-2):135-9. PubMed ID: 9085088
[TBL] [Abstract][Full Text] [Related]
50. Effect of unilateral nephrectomy on renal function of diabetic rats.
Lopes GS; Lemos CC; Mandarim-De-Lacerda CA; Bregman R
Histol Histopathol; 2004 Oct; 19(4):1085-8. PubMed ID: 15375750
[TBL] [Abstract][Full Text] [Related]
51. Effects of a PAF-antagonist (WEB 2086) on hyperacute xenogeneic rejection in ex vivo perfused kidneys.
Bergmann R; Saumweber DM; Brecht HM; Hammer C
Transplant Proc; 1990 Aug; 22(4):2009-10. PubMed ID: 2389511
[No Abstract] [Full Text] [Related]
52. Nephrotoxicity of cyclosporine A in rats with a diminished renal function.
Provoost AP; Kaptein L; Van Aken M
Clin Nephrol; 1986; 25 Suppl 1():S162-7. PubMed ID: 3519023
[TBL] [Abstract][Full Text] [Related]
53. Overexpression of angiotensin type 2 receptor ameliorates glomerular injury in a mouse remnant kidney model.
Hashimoto N; Maeshima Y; Satoh M; Odawara M; Sugiyama H; Kashihara N; Matsubara H; Yamasaki Y; Makino H
Am J Physiol Renal Physiol; 2004 Mar; 286(3):F516-25. PubMed ID: 14583437
[TBL] [Abstract][Full Text] [Related]
54. Role of platelet-activating factor in mediating tumor necrosis factor alpha-induced pulmonary vasoconstriction and plasma-lymph protein transport.
Horvath CJ; Kaplan JE; Malik AB
Am Rev Respir Dis; 1991 Dec; 144(6):1337-41. PubMed ID: 1741548
[TBL] [Abstract][Full Text] [Related]
55. Differential renal glomerular changes induced by 5/6 nephrectomization between common marmoset monkeys (Callithrix jacchus) and rats.
Suzuki Y; Yamaguchi I; Onoda N; Saito T; Myojo K; Imaizumi M; Takada C; Kimoto N; Takaba K; Yamate J
Exp Toxicol Pathol; 2013 Jul; 65(5):667-76. PubMed ID: 22986225
[TBL] [Abstract][Full Text] [Related]
56. Survival of renal allografted dogs after limited therapy with cyclosporine and the PAF antagonist WEB 2170.
Metcalfe SM; Watson CJ; Collier DG; DaCosta M; Friend PJ; Pollard SG; Luddington R; Calne RY
Transplant Proc; 1991 Aug; 23(4):2219-20. PubMed ID: 1871852
[No Abstract] [Full Text] [Related]
57. Renal function in different forms of renovascular hypertension in rats.
Eklöf AC; Aperia A
Acta Physiol Scand; 1989 Jul; 136(3):487-92. PubMed ID: 2750542
[TBL] [Abstract][Full Text] [Related]
58. Platelet-activating factor mediates monocyte chemoattractant protein-1 expression in glomerular immune injury.
Jocks T; Freudenberg J; Zahner G; Stahl RA
Nephrol Dial Transplant; 1998 Jan; 13(1):37-43. PubMed ID: 9481713
[TBL] [Abstract][Full Text] [Related]
59. WEB-2086 and indomethacin do not modify blood pressure fall on unclipping hypertensive rats.
Smith AJ; Gerkens JF; Dosen P
Clin Exp Pharmacol Physiol; 1994 May; 21(5):413-6. PubMed ID: 7955550
[TBL] [Abstract][Full Text] [Related]
60. An extremely high dose of losartan affords superior renoprotection in the remnant model.
Fujihara CK; Velho M; Malheiros DM; Zatz R
Kidney Int; 2005 May; 67(5):1913-24. PubMed ID: 15840039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
